CVS Health · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← CVS

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	106.10	+7.3%	44.5%	4.70	2.98	2.8%	5.65	2.31	—	0.88
FY2026 Q1	2026-03-31	100.43	+6.2%	44.8%	4.68	2.94	2.9%	3.40	2.30	—	0.85
FY2025 Q4	2025-12-31	105.69	+8.2%	44.1%	2.11	2.94	2.8%	2.61	2.31	0.00	0.85
FY2025 Q3	2025-09-30	102.87	+7.8%	44.5%	-3.21	-3.98	-3.9%	0.10	-3.13	0.00	0.85
FY2025 Q2	2025-06-30	98.92	+8.4%	45.4%	2.38	1.02	1.0%	1.29	0.80	0.00	0.87
FY2025 Q1	2025-03-31	94.59	+7.0%	46.0%	3.37	1.78	1.9%	3.81	1.41	0.00	0.84
FY2024 Q4	2024-12-31	97.71	+4.2%	43.4%	2.37	1.64	1.7%	1.09	1.30	0.00	0.84
FY2024 Q3	2024-09-30	95.43	+6.3%	44.5%	0.83	0.09	0.1%	-1.42	0.07	-0.00	0.84
FY2024 Q2	2024-06-30	91.23	+2.6%	45.2%	3.05	1.77	1.9%	2.45	1.41	-0.00	0.86
FY2024 Q1	2024-03-31	88.44	+3.7%	45.6%	2.27	1.11	1.3%	4.20	0.88	3.03	0.84
FY2023 Q4	2023-12-31	93.81	+11.9%	38.8%	3.37	2.05	2.2%	-3.55	1.59	-0.00	0.78
FY2023 Q3	2023-09-30	89.76	+10.6%	39.1%	3.69	2.26	2.5%	2.17	1.75	-0.00	0.78
FY2023 Q2	2023-06-30	88.92	—	39.8%	3.23	1.90	2.1%	5.32	1.48	-0.00	0.80
FY2023 Q1	2023-03-31	85.28	—	39.7%	3.45	2.14	2.5%	6.45	1.65	2.02	0.78
FY2022 Q4	2022-12-31	83.85	—	38.3%	3.66	2.33	2.8%	-2.64	1.79	1.50	0.72
FY2022 Q3	2022-09-30	81.16	—	37.9%	-3.92	-3.41	-4.2%	8.54	-2.59	0.00	0.73

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.